Literature DB >> 14570743

Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues.

Robert P Thomas1, Mark R Hellmich, Courtney M Townsend, B Mark Evers.   

Abstract

Gastrointestinal (GI) hormones are chemical messengers that regulate the physiological functions of the intestine and pancreas, including secretion, motility, absorption, and digestion. In addition to these well-defined physiological effects, GI hormones can stimulate proliferation of the nonneoplastic intestinal mucosa and pancreas. Furthermore, in an analogous fashion to breast and prostate cancer, certain GI cancers possess receptors for GI hormones; growth can be altered by administration of these hormones or by blocking their respective receptors. The GI hormones that affect proliferation, either stimulatory or inhibitory, include gastrin, cholecystokinin, gastrin-releasing peptide, neurotensin, peptide YY, glucagon-like peptide-2, and somatostatin. The effects of these peptides on normal and neoplastic GI tissues will be described. Also, future perspectives and potential therapeutic implications will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570743     DOI: 10.1210/er.2002-0028

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  42 in total

1.  Characterization of promoter elements regulating the expression of the human neurotensin/neuromedin N gene.

Authors:  Xiaofu Wang; Pat Gulhati; Jing Li; Paul R Dobner; Heidi Weiss; Courtney M Townsend; B Mark Evers
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

Review 2.  Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines.

Authors:  Patrick Kitabgi
Journal:  J Mol Med (Berl)       Date:  2006-05-11       Impact factor: 4.599

3.  Hypergastrinemia--diagnosis and treatment.

Authors:  Bruno Niederle
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.

Authors:  Kohei Hashimoto; Yuki Kyoda; Toshiaki Tanaka; Toshihiro Maeda; Ko Kobayashi; Kohsuke Uchida; Hiroshi Kitamura; Koichi Hirata; Taiji Tsukamoto; Naoya Masumori
Journal:  Lab Invest       Date:  2015-01-12       Impact factor: 5.662

5.  Cinnamtannin B-1, a natural antioxidant that reduces the effects of H(2)O(2) on CCK-8-evoked responses in mouse pancreatic acinar cells.

Authors:  Antonio Gonzalez; Patricia Santofimia-Castaño; Ramon Rivera-Barreno; Gines M Salido
Journal:  J Physiol Biochem       Date:  2011-11-26       Impact factor: 4.158

6.  Melatonin modulates Ca2+ mobilization and amylase release in response to cholecystokinin octapeptide in mouse pancreatic acinar cells.

Authors:  Patricia Santofimia-Castaño; Deborah Clea Ruy; Ginés M Salido; Antonio González
Journal:  J Physiol Biochem       Date:  2013-08-02       Impact factor: 4.158

7.  Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells.

Authors:  Qingding Wang; Yuning Zhou; B Mark Evers
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

8.  Prognostic significance of gastrin expression in patients undergoing R0 gastrectomy for adenocarcinoma.

Authors:  Michael R Stephens; Andrew N Hopper; Wyn G Lewis; Guy Blackshaw; Paul Edwards; Becky Osborne; Ian W Thompson
Journal:  Gastric Cancer       Date:  2007-09-26       Impact factor: 7.370

9.  Pharmacological dose of melatonin reduces cytosolic calcium load in response to cholecystokinin in mouse pancreatic acinar cells.

Authors:  Patricia Santofimia-Castaño; Deborah Clea Ruy; Miguel Fernandez-Bermejo; Gines M Salido; Antonio Gonzalez
Journal:  Mol Cell Biochem       Date:  2014-08-02       Impact factor: 3.396

10.  Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.

Authors:  Ulrike Olszewski; Gerhard Hamilton
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.